Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.
2.

Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.

Lee AJ, Lowe GD, Smith WC, Tunstall-Pedoe H.

Br J Haematol. 1993 Apr;83(4):616-21.

PMID:
8518178
3.

Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.

Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT.

Menopause. 2006 Mar-Apr;13(2):265-79. Review.

PMID:
16645540
4.
5.

Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.

Al-Farra HM, Al-Fahoum SK, Tabbaa MA.

Saudi Med J. 2005 Dec;26(12):1930-5.

PMID:
16380775
6.

Menopause and determinants of quality of life in women at midlife and beyond: the study of health in pomerania (SHIP).

Schwarz S, Völzke H, Alte D, Schwahn C, Grabe HJ, Hoffmann W, John U, Dören M.

Menopause. 2007 Jan-Feb;14(1):123-34.

PMID:
17019378
7.

Persistent hot flushes in older postmenopausal women.

Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF.

Arch Intern Med. 2008 Apr 28;168(8):840-6. doi: 10.1001/archinte.168.8.840.

PMID:
18443259
8.

Factors associated with glucose and insulin levels in healthy postmenopausal women.

Barrett-Connor E, Schrott HG, Greendale G, Kritz-Silverstein D, Espeland MA, Stern MP, Bush T, Perlman JA.

Diabetes Care. 1996 Apr;19(4):333-40.

PMID:
8729156
9.

Replacement estrogen use and body mass index.

García Rodríguez LA, Pfaff GM, Schumacher MC, Walker AM, Hoffmeister H.

Epidemiology. 1990 May;1(3):219-23.

PMID:
2081256
10.

Breast cancer risk: effects of estrogen replacement therapy and body mass.

Harris RE, Namboodiri KK, Wynder EL.

J Natl Cancer Inst. 1992 Oct 21;84(20):1575-82.

PMID:
1404451
11.

Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?

LaRosa JC.

Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3.

PMID:
1617306
12.

Effect of lifestyle factors and hormone therapy on heart function by serial echocardiography in postmenopausal women.

Khoo SK, O'Neill S, Scalia G, Tripcony L.

Aust N Z J Obstet Gynaecol. 2010 Feb;50(1):87-92. doi: 10.1111/j.1479-828X.2009.01112.x.

PMID:
20219004
13.
14.

Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.

Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.

Metabolism. 1997 Jan;46(1):5-9.

PMID:
9005961
15.

Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.

Windler E, Zyriax BC, Eidenmüller B, Boeing H.

Maturitas. 2007 Jul 20;57(3):239-46. Epub 2007 Feb 9.

PMID:
17292571
16.

Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.

Otsuki M, Kasayama S, Morita S, Asanuma N, Saito H, Mukai M, Koga M.

Menopause. 2007 May-Jun;14(3 Pt 1):404-7.

PMID:
17213751
17.

Hormone replacement therapy and glucose tolerance in EPIC-Norfolk: a population-based study.

Sargeant LA, Wareham NJ, Khaw KT.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):20-5.

PMID:
10707035
18.

Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.

Amigoni S, Morelli P, Chatenoud L, Parazzini F.

Climacteric. 2000 Mar;3(1):25-32.

PMID:
11910606
19.

Menopause and serum cholesterol: differences between blacks and whites. The Minnesota Heart Survey.

Demirovic J, Sprafka JM, Folsom AR, Laitinen D, Blackburn H.

Am J Epidemiol. 1992 Jul 15;136(2):155-64.

PMID:
1357959
20.

Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.

Meilahn EN, Cauley JA, Tracy RP, Macy EO, Gutai JP, Kuller LH.

Am J Epidemiol. 1996 Jan 15;143(2):159-66.

PMID:
8546117

Supplemental Content

Support Center